A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT07225946 · RECRUITING
Trial details
- NCT number
- NCT07225946
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-19
- Primary completion
- 2027-11-19
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.